A Cell Cycle-Dependent Ferroptosis Sensitivity Switch Governed by EMP2.
EMP2
Lipid peroxidation
MBOAT1
MUFA
PUFA
ferroptosis
p53
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
19 Jul 2023
19 Jul 2023
Historique:
pubmed:
28
7
2023
medline:
28
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Ferroptosis is a non-apoptotic form of cell death characterized by iron-dependent lipid peroxidation. Ferroptosis can be induced by system x
Identifiants
pubmed: 37502927
doi: 10.1101/2023.07.19.549715
pmc: PMC10370086
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NCI NIH HHS
ID : F31 CA265146
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA262439
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM112948
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM122923
Pays : United States
Déclaration de conflit d'intérêts
DECLARATION OF INTERESTS S.J.D. is a founder of Prothegen Inc., a member of the scientific advisory board of Ferro Therapeutics and Hillstream Biopharma, and an inventor on patents related to ferroptosis.